Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transdermal clonidine for ameliorating post-orchiectomy hot flashes

C L Loprinzi1, R M Goldberg, J R O'Fallon

  • 1Department of Urology, Mayo Clinic, Rochester, Minnesota.

The Journal of Urology
|March 1, 1994
PubMed
Summary

Transdermal clonidine did not effectively reduce hot flash frequency or severity in men treated for prostate cancer. Further research is needed to identify treatments for post-orchiectomy hot flashes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sheep recombinant IGF-1 promotes organ-specific growth in fetal sheep.

Frontiers in physiology·2022
Same author

Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither?

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Pulsatile hyperglycemia increases insulin secretion but not pancreatic β-cell mass in intrauterine growth-restricted fetal sheep.

Journal of developmental origins of health and disease·2018
Same author

The past and future of 'reported outcomes' in studies on chemotherapy neuropathy.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Cancer-Associated Anorexia and Cachexia : Implications for Drug Therapy.

Drugs·2017
Same author

Prostate cancer: state of the art imaging and focal treatment.

Clinical radiology·2017

Area of Science:

  • Oncology
  • Urology
  • Dermatology

Background:

  • Hot flashes are a common side effect of orchiectomy in prostate cancer patients.
  • Existing treatments for hot flashes may have limitations or side effects.

Purpose of the Study:

  • To evaluate the efficacy of transdermal clonidine in managing hot flashes after orchiectomy.
  • To assess the impact of clonidine on hot flash frequency and severity.

Main Methods:

  • A randomized, double-blind, crossover trial was conducted.
  • Seventy men with prostate cancer who underwent orchiectomy and experienced hot flashes participated.
  • Participants received either transdermal clonidine or a placebo.

Main Results:

Related Experiment Videos

  • Transdermal clonidine did not significantly reduce the frequency of hot flashes.
  • Clonidine also failed to significantly decrease the severity of hot flashes.
  • No significant difference in hot flash symptom relief was observed between clonidine and placebo.

    • Conclusions:

    • Transdermal clonidine is not an effective treatment for post-orchiectomy hot flashes in prostate cancer patients.
    • Further investigation is required to find effective interventions for managing this common side effect.
    • Developing better symptom management strategies is crucial for improving patient quality of life.